Los Angeles Capital Management LLC Has $10.65 Million Stake in Chemed Co. (NYSE:CHE)

Los Angeles Capital Management LLC grew its position in Chemed Co. (NYSE:CHE) by 30.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,723 shares of the company’s stock after acquiring an additional 4,136 shares during the period. Los Angeles Capital Management LLC owned 0.12% of Chemed worth $10,651,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of CHE. GAMMA Investing LLC grew its holdings in shares of Chemed by 34.4% in the 2nd quarter. GAMMA Investing LLC now owns 86 shares of the company’s stock valued at $47,000 after buying an additional 22 shares during the period. American National Bank & Trust acquired a new stake in Chemed in the 3rd quarter valued at about $61,000. EntryPoint Capital LLC boosted its position in Chemed by 14.0% during the first quarter. EntryPoint Capital LLC now owns 147 shares of the company’s stock worth $94,000 after purchasing an additional 18 shares during the period. Mather Group LLC. raised its holdings in Chemed by 60.5% in the 2nd quarter. Mather Group LLC. now owns 183 shares of the company’s stock valued at $99,000 after acquiring an additional 69 shares during the period. Finally, Quarry LP lifted its holdings in Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after purchasing an additional 166 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Trading Up 0.7 %

Shares of Chemed stock opened at $562.15 on Tuesday. The firm has a market capitalization of $8.46 billion, a PE ratio of 28.41, a price-to-earnings-growth ratio of 2.37 and a beta of 0.46. The firm’s 50 day moving average is $581.72 and its 200 day moving average is $565.43. Chemed Co. has a 1 year low of $523.33 and a 1 year high of $654.62.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. During the same quarter in the previous year, the company posted $5.32 earnings per share. The firm’s revenue was up 7.4% on a year-over-year basis. As a group, research analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.36%. Chemed’s dividend payout ratio is presently 10.11%.

Insiders Place Their Bets

In other news, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the transaction, the director now owns 3,046 shares in the company, valued at approximately $1,819,893.62. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director George J. Walsh III sold 400 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total value of $238,988.00. Following the sale, the director now directly owns 3,046 shares in the company, valued at $1,819,893.62. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $569.35, for a total transaction of $975,296.55. Following the sale, the executive vice president now directly owns 6,109 shares of the company’s stock, valued at $3,478,159.15. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,144 shares of company stock valued at $3,002,419 in the last ninety days. 3.32% of the stock is currently owned by insiders.

Analyst Ratings Changes

Separately, Royal Bank of Canada decreased their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.